Bupropion is used widely as a smoking cessation aid and antidepressant and is available in
immediate-and extendedrelease preparations. It blocks neuronal reuptake of dopamine and …

Bupropion is an antidepressant commonly prescribed as a smoking cessation aid. It has
effects on dopamine and norepinephrine, and can lower seizure threshold, particularly in …

Discussion: Bupropion seems to have addictive effects, particularly when administered
intravenously or intranasally. Individuals who inject high doses of bupropion may be at risk …

Cigarette smoking represents one of the most preventable causes of death worldwide.
However, success rates for stopping smoking are disappointingly low and are associated …

Tobacco use, particularly cigarette smoking, is now a global pandemic. The expected
morbidity and mortality from smoking-attributable diseases will continue to rise for the next …

Sustained release bupropion (amfebutamone) is a non-nicotine agent that is indicated as an
aid to smoking cessation. In 2 large well designed clinical trials, sustained release …

Background: Bupropion has been available in the United States since 1989. Initially a
thricedaily immediate-release formulation, a twicedaily sustained-release formulation …

Background: Bupropion is a substituted cathinone compound widely used as a first line or
add-on treatment for depression, smoking cessation, and more recently in combination with …

The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major
change in the options available for smoking cessation pharmacotherapy. Bupropion is a …

Background: Therapeutic use, overdose and recreational abuse of bupropion are
increasing. The purpose of this study was to describe the incidence and outcomes of …